A pilot study: sequential gemcitabine/cisplatin and icotinib as induction therapy for stage IIB to IIIA non-small-cell lung adenocarcinoma

BACKGROUND: A phase II clinical trial previously evaluated the sequential administration of erlotinib after chemotherapy for advanced non-small-cell lung cancer (NSCLC). This current pilot study assessed the feasibility of sequential induction therapy in patients with stage IIB to IIIA NSCLC adenoca...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Chao, Ma, Yuanyuan, Feng, Qin, Fang, Fang, Bai, Hua, Zhao, Bingtian, Yan, Shi, Wu, Nan, Zheng, Qingfeng, Li, Shaolei, Chen, Jinfeng, Wang, Jia, Feng, Yuan, Wang, Yuzhao, Pei, Yuquan, Fang, Jian, Yang, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643858/
https://www.ncbi.nlm.nih.gov/pubmed/23621919
http://dx.doi.org/10.1186/1477-7819-11-96

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643858/
https://www.ncbi.nlm.nih.gov/pubmed/23621919
http://dx.doi.org/10.1186/1477-7819-11-96

Ejemplares similares